CMR về tắc nghẽn vi mạch và chảy máu trong nhồi máu cơ tim

Kloner RA, Ganote CE, Jennings RB: The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974, 54: 1496-508. 10.1172/JCI107898. Reffelmann T, Kloner RA: The "no-reflow" phenomenon: basic science and clinical correlates. Heart. 2002, 87: 162-8. 10.1136/heart.87.2.162. Reffelmann T, Kloner RA: The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol. 2006, 101: 359-72. 10.1007/s00395-006-0615-2. Ambrosio G, Weisman HF, Mannisi JA, Becker LC: Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989, 80: 1846-61. 10.1161/01.CIR.80.6.1846. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA: Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995, 92: 1902-10. 10.1161/01.CIR.92.7.1902. Schwartz BG, Kloner RA: Coronary no reflow. J Mol Cell Cardiol. 2011, 52: 873-82. Heusch G, Kleinbongard P, Bose D, Levkau B, Haude M, Schulz R, Erbel R: Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009, 120: 1822-36. 10.1161/CIRCULATIONAHA.109.888784. van Rugge FP, van der Wall EE, van Dijkman PR, Louwerenburg HW, de Roos A, Bruschke AV: Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol. 1992, 70: 1233-7. 10.1016/0002-9149(92)90754-M. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR: First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol. 1991, 18: 959-65. 10.1016/0735-1097(91)90754-W. Wilke N, Simm C, Zhang J, Ellermann J, Ya X, Merkle H, Path G, Ludemann H, Bache RJ, Ugurbil K: Contrast-enhanced first pass myocardial perfusion imaging: correlation between myocardial blood flow in dogs at rest and during hyperemia. Magn Reson Med. 1993, 29: 485-97. 10.1002/mrm.1910290410. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation. 1995, 92: 1117-25. 10.1161/01.CIR.92.5.1117. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, Lima JA: Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 1998, 32: 1756-64. 10.1016/S0735-1097(98)00429-X. Judd RM, Reeder SB, Atalar E, McVeigh ER, Zerhouni EA: A magnetization-driven gradient echo pulse sequence for the study of myocardial perfusion. Magn Reson Med. 1995, 34: 276-82. 10.1002/mrm.1910340220. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, Becker LC, Melin JA: Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998, 98: 1006-14. 10.1161/01.CIR.98.10.1006. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG: Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation. 2004, 109: 2080-5. 10.1161/01.CIR.0000127812.62277.50. Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, Mester J, Higgins CB, Adam G, Meinertz T: Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology. 2004, 232: 49-57. 10.1148/radiol.2321031127. Yan AT, Gibson CM, Larose E, Anavekar NS, Tsang S, Solomon SD, Reynolds G, Kwong RY: Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson. 2006, 8: 831-7. 10.1080/10976640600778049. Bekkers SC, Backes WH, Kim RJ, Snoep G, Gorgels AP, Passos VL, Waltenberger J, Crijns HJ, Schalla S: Detection and characteristics of microvascular obstruction in reperfused acute myocardial infarction using an optimized protocol for contrast-enhanced cardiovascular magnetic resonance imaging. Eur Radiol. 2009, 19: 2904-12. 10.1007/s00330-009-1489-0. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG, Visser CA, van Rossum AC: Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003, 42: 895-901. 10.1016/S0735-1097(03)00835-0. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005, 26: 549-57. Mather AN, Lockie T, Nagel E, Marber M, Perera D, Redwood S, Radjenovic A, Saha A, Greenwood JP, Plein S: Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson. 2009, 11: 11-33. 10.1186/1532-429X-11-11. Reffelmann T, Kloner RA: Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit. Am J Physiol Heart Circ Physiol. 2002, 283: H1099-107. Kloner RA: No-reflow phenomenon: maintaining vascular integrity. J Cardiovasc Pharmacol Ther. 2011, 16: 244-50. 10.1177/1074248411405990. Amado LC, Kraitchman DL, Gerber BL, Castillo E, Boston RC, Grayzel J, Lima JA: Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol. 2004, 43: 1291-8. 10.1016/j.jacc.2003.11.034. Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC, Becker LC, Lima JA: Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation. 2000, 101: 2734-41. 10.1161/01.CIR.101.23.2734. Asanuma T, Tanabe K, Ochiai K, Yoshitomi H, Nakamura K, Murakami Y, Sano K, Shimada T, Murakami R, Morioka S, Beppu S: Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction: myocardial contrast echocardiographic study. Circulation. 1997, 96: 448-53. 10.1161/01.CIR.96.2.448. Reffelmann T, Hale SL, Dow JS, Kloner RA: No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2003, 108: 2911-7. 10.1161/01.CIR.0000101917.80668.E1. Sakuma T, Hayashi Y, Shimohara A, Shindo T, Maeda K: Usefulness of myocardial contrast echocardiography for the assessment of serial changes in risk area in patients with acute myocardial infarction. Am J Cardiol. 1996, 78: 1273-7. 10.1016/S0002-9149(96)00610-8. Ghugre NR, Ramanan V, Pop M, Yang Y, Barry J, Qiang B, Connelly KA, Dick AJ, Wright GA: Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med. 2011, 66: 1129-41. 10.1002/mrm.22855. Orn S, Manhenke C, Greve OJ, Larsen AI, Bonarjee VV, Edvardsen T, Dickstein K: Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J. 2009, 30: 1978-85. 10.1093/eurheartj/ehp219. Ito H, Iwakura K, Oh H, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T: Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability. Circulation. 1995, 91: 656-62. 10.1161/01.CIR.91.3.656. Funaro S, Galiuto L, Boccalini F, Cimino S, Canali E, Evangelio F, DeLuca L, Paraggio L, Mattatelli A, Gnessi L, Agati L: Determinants of microvascular damage recovery after acute myocardial infarction: results from the acute myocardial infarction contrast imaging (AMICI) multi-centre study. Eur J Echocardiogr. 2011, 12: 306-12. 10.1093/ejechocard/jer009. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S: Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology. 2011, 261: 116-26. 10.1148/radiol.11110228. Galiuto L: Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification. Heart. 2004, 90: 123-5. 10.1136/hrt.2003.020800. Kleinbongard P, Konorza T, Bose D: Lessons from human coronary aspirate. J Mol Cell Cardiol. 2011, 52: 890-6. Selvanayagam JB, Cheng AS, Jerosch-Herold M, Rahimi K, Porto I, van Gaal W, Channon KM, Neubauer S, Banning AP: Effect of distal embolization on myocardial perfusion reserve after percutaneous coronary intervention: a quantitative magnetic resonance perfusion study. Circulation. 2007, 116: 1458-64. 10.1161/CIRCULATIONAHA.106.671909. Wong DT, Leung MC, Richardson JD, Puri R, Bertaso AG, Williams K, Meredith IT, Teo KS, Worthley MI, Worthley SG: Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements. Int J Cardiovasc Imaging. 2012, Epub ahead of print Luo AK, Wu KC: Imaging microvascular obstruction and its clinical significance following acute myocardial infarction. Heart Fail Rev. 2006, 11: 305-312. 10.1007/s10741-006-0231-0. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D: Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation. 2004, 109: 1121-1126. 10.1161/01.CIR.0000118496.44135.A7. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T: Clinical implications of the 'no reflow' phenomenon. a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996, 93: 223-228. 10.1161/01.CIR.93.2.223. Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schomig A, Kastrati A: 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010, 55: 2383-2389. 10.1016/j.jacc.2009.12.054. Rezkalla SH, Dharmashankar KC, Abdalrahman IB, Kloner RA: No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010, 23: 429-436. 10.1111/j.1540-8183.2010.00561.x. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998, 97: 765-772. 10.1161/01.CIR.97.8.765. Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV: Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen". Herz. 2008, 33: 136-142. 10.1007/s00059-008-3102-8. Cochet AA, Lorgis L, Lalande A, Zeller M, Beer JC, Walker PM, Touzery C, Wolf JE, Brunotte F, Cottin Y: Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol. 2009, 19: 2117-2126. 10.1007/s00330-009-1395-5. de Waha S, Desch S, Eitel I, Fuernau G, Zachrau J, Leuschner A, Gutberlet M, Schuler G, Thiele H: Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J. 2010, 31: 2660-2668. 10.1093/eurheartj/ehq247. Bodi V, Sanchis J, Nunez J, Mainar L, Lopez-Lereu MP, Monmeneu JV, Rumiz E, Chaustre F, Trapero I, Husser O: Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging. 2009, 2: 835-842. 10.1016/j.jcmg.2009.03.011. Larose E, Rodes-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM, Dery JP, Gleeton O, Roy L, Noel B: Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol. 2010, 55: 2459-2469. 10.1016/j.jacc.2010.02.033. Nijveldt R, Beek AM, Hirsch A, Stoel MG, Hofman MB, Umans VA, Algra PR, Twisk JW, van Rossum AC: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol. 2008, 52: 181-189. 10.1016/j.jacc.2008.04.006. Weir RA, Murphy CA, Petrie CJ, Martin TN, Balmain S, Clements S, Steedman T, Wagner GS, Dargie HJ, McMurray JJ: Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging. 2010, 3: 360-367. 10.1161/CIRCIMAGING.109.897439. Wu KC: Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction?. JACC Cardiovasc Imaging. 2009, 2: 843-845. 10.1016/j.jcmg.2009.02.013. Fishbein MC, YR J, Lando U, Kanmatsuse K, Mercier JC, Ganz W: The relationship of vascular injury and myocardial hemorrhage to necrosis after reperfusion. Circulation. 1980, 62: 1274-1279. 10.1161/01.CIR.62.6.1274. Higginson LA, Beanlands DS, Nair RC, Temple V, Sheldrick K: The time course and characterization of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Circulation. 1983, 67: 1024-1031. 10.1161/01.CIR.67.5.1024. Higginson LA, White F, Heggtveit HA, Sanders TM, Bloor CM, Covell JW: Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog. Circulation. 1982, 65: 62-69. 10.1161/01.CIR.65.1.62. Pislaru SV, Barrios L, Stassen T, Jun L, Pislaru C, Van de Werf F: Infarct size, myocardial hemorrhage, and recovery of function after mechanical versus pharmacological reperfusion: effects of lytic state and occlusion time. Circulation. 1997, 96: 659-666. 10.1161/01.CIR.96.2.659. Garcia-Dorado D, Theroux P, Solares J, Alonso J, Fernandez-Aviles F, Elizaga J, Soriano J, Botas J, Munoz R: Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol. 1990, 137: 301-311. Braunwald E, Kloner RA: Myocardial reperfusion: a double-edged sword?. J Clin Invest. 1985, 76: 1713-1719. 10.1172/JCI112160. Fujiwara H, Onodera T, Tanaka M, Fujiwara T, Wu DJ, Kawai C, Hamashima Y: A clinicopathologic study of patients with hemorrhagic myocardial infarction treated with selective coronary thrombolysis with urokinase. Circulation. 1986, 73: 749-757. 10.1161/01.CIR.73.4.749. Kloner RA, Alker KJ: The effect of streptokinase on intramyocardial hemorrhage, infarct size, and the no-reflow phenomenon during coronary reperfusion. Circulation. 1984, 70: 513-521. 10.1161/01.CIR.70.3.513. Massel DR: How sound is the evidence that thrombolysis increases the risk of cardiac rupture?. Br Heart J. 1993, 69: 284-287. 10.1136/hrt.69.4.284. Kloner RA, Alker K, Campbell C, Figures G, Eisenhauer A, Hale S: Does tissue-type plasminogen activator have direct beneficial effects on the myocardium independent of its ability to lyse intracoronary thrombi?. Circulation. 1989, 79: 1125-1136. 10.1161/01.CIR.79.5.1125. Basso C, Thiene G: The pathophysiology of myocardial reperfusion: a pathologist's perspective. Heart. 2006, 92: 1559-1562. 10.1136/hrt.2005.086959. Anzalone N, Scotti R, Riva R: Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci. 2004, 25 (Suppl 1): S3-5. Bradley WG: MR appearance of hemorrhage in the brain. Radiology. 1993, 189: 15-26. Lotan CS, Bouchard A, Cranney GB, Bishop SP, Pohost GM: Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T. Circulation. 199, 86: 1018-1025. Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, Bogaert J: Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009, 30: 1440-1449. 10.1093/eurheartj/ehp093. Eitel I, Kubusch K, Strohm O, Desch S, Mikami Y, de Waha S, Gutberlet M, Schuler G, Friedrich MG, Thiele H: Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011, 4: 354-362. 10.1161/CIRCIMAGING.110.960500. Basso C, Corbetti F, Silva C, Abudureheman A, Lacognata C, Cacciavillani L, Tarantini G, Marra MP, Ramondo A, Thiene G, Iliceto S: Morphologic validation of reperfused hemorrhagic myocardial infarction by cardiovascular magnetic resonance. Am J Cardiol. 2007, 100: 1322-1327. 10.1016/j.amjcard.2007.05.062. Jackowski C, Christe A, Sonnenschein M, Aghayev E, Thali MJ: Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization. Eur Heart J. 2006, 27: 2459-2467. 10.1093/eurheartj/ehl255. Mikami Y, Sakuma H, Nagata M, Ishida M, Kurita T, Komuro I, Ito M: Relation between signal intensity on T2-weighted MR images and presence of microvascular obstruction in patients with acute myocardial infarction. AJR Am J Roentgenol. 2009, 193: W321-326. 10.2214/AJR.09.2335. Cannan C, Eitel I, Hare J, Kumar A, Friedrich M: Hemorrhage in the myocardium following infarction. JACC Cardiovasc Imaging. 2010, 3: 665-668. 10.1016/j.jcmg.2009.12.019. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP: T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009, 11: 56-10.1186/1532-429X-11-56. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, Raman SV: Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011, 4: 269-278. 10.1016/j.jcmg.2010.09.023. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM: Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics. 2009, 29: 1433-1449. 10.1148/rg.295095034. O'Regan DP, Ahmed R, Karunanithy N, Neuwirth C, Tan Y, Durighel G, Hajnal JV, Nadra I, Corbett SJ, Cook SA: Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology. 2009, 250: 916-922. 10.1148/radiol.2503081154. Kumar A, Green JD, Sykes JM, Ephrat P, Carson JJ, Mitchell AJ, Wisenberg G, Friedrich MG: Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging. 2011, 4: 1274-1283. 10.1016/j.jcmg.2011.08.016. Ochiai K, Shimada T, Murakami Y, Ishibashi Y, Sano K, Kitamura J, Inoue S, Murakami R, Kawamitsu H, Sugimura K: Hemorrhagic myocardial infarction after coronary reperfusion detected in vivo by magnetic resonance imaging in humans: prevalence and clinical implications. J Cardiovasc Magn Reson. 1999, 1: 247-256. 10.3109/10976649909088337. O'Regan DP, Ariff B, Neuwirth C, Tan Y, Durighel G, Cook SA: Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart. 2010, 96: 1885-1891. 10.1136/hrt.2010.200634. Linfante I, Llinas RH, Caplan LR, Warach S: MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke. 1999, 30: 2263-2267. 10.1161/01.STR.30.11.2263. Wiesmann M, Mayer TE, Yousry I, Hamann GF, Bruckmann H: Detection of hyperacute parenchymal hemorrhage of the brain using echo-planar T2*-weighted and diffusion-weighted MRI. Eur Radiol. 2001, 11: 849-853. 10.1007/s003300000649. Mather AN, Fairbairn TA, Ball SG, Greenwood JP, Plein S: Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart. 2010, 97: 453-459. Tarantini G, Favaretto E, Napodano M, Perazzolo Marra M, Cacciavillani L, Babuin L, Giovagnoni A, Renda P, De Biasio V, Plebani M: Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. Cardiology. 2010, 116: 110-116. 10.1159/000316967. Ludman AJ, Yellon DM, Hasleton J, Ariti C, Babu GG, Boston-Griffiths E, Venugopal V, Walker M, Holdright D, Swanton H: Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial. Heart. 2011, 97: 1560-1565. 10.1136/hrt.2011.223867. Patel MR, Smalling RW, Thiele H, Barnhart HX, Zhou Y, Chandra P, Chew D, Cohen M, French J, Perera D, Ohman EM: Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial. JAMA. 2011, 306: 1329-1337. 10.1001/jama.2011.1280. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T: Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST segment elevation myocardial infarction (results of the F.I.R.E. trial). J Am Coll Cardiol. 2008, in press Cassese S, Esposito G, Mauro C, Varbella F, Carraturo A, Montinaro A, Cirillo P, Galasso G, Rapacciuolo A, Piscione F: MGUard versus bAre-metal stents plus manual thRombectomy in ST-elevation myocarDial Infarction pAtieNts - (GUARDIAN) Trial: study design and rationale. Catheter Cardiovasc Interv. 2011, 79: 1118-1126. Wohrle J, Merkle N, Kunze M: Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: The horizons-AMI CMRI substudy. Catheter Cardiovasc Interv. 2011, 79: 1083-1089. Desmet W, Bogaert J, Dubois C, Sinnaeve P, Adriaenssens T, Pappas C, Ganame J, Dymarkowski S, Janssens S, Belmans A, Van de Werf F: High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J. 2011, 32: 867-877. 10.1093/eurheartj/ehq492. Gibson CM, Maehara A, Lansky AJ, Wohrle J, Stuckey T, Dave R, Cox D, Grines C, Dudek D, Steg G: Rationale and design of the INFUSE-AMI study: a 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. Am Heart J. 2011, 161: 478-486. 10.1016/j.ahj.2010.10.006. e477 Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E, Erbs S, Linke A, Mobius-Winkler S, Kivelitz D, Schuler G: Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation. 2008, 118: 49-57. 10.1161/CIRCULATIONAHA.107.747642. Thiele H, Wohrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R, Birkemeyer R, Wiemer M, Kerber S, Schuehlen H: Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial. Am Heart J. 2010, 159: 547-554. 10.1016/j.ahj.2009.12.038. Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G: Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction). JACC Cardiovasc Interv. 2011, 4: 605-614. 10.1016/j.jcin.2011.01.013. Prunier F, Biere L, Gilard M, Boschat J, Mouquet F, Bauchart JJ, Charbonnier B, Genee O, Guerin P, Warin-Fresse K: Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial. Am Heart J. 2012, 163: 200-207. 10.1016/j.ahj.2011.11.005. e201 Strauer BE, Steinhoff G: 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice. J Am Coll Cardiol. 2011, 58: 1095-1104. 10.1016/j.jacc.2011.06.016. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marban L, Mendizabal A, Johnston PV: Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012 Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, Kalantzi M, Herbots L, Sinnaeve P, Dens J: Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006, 367: 113-121. 10.1016/S0140-6736(05)67861-0. Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S: Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart. 2009, 95: 1983-1989. 10.1136/hrt.2009.178913. Ye Y, Bogaert J: Cell therapy in myocardial infarction: emphasis on the role of MRI. Eur Radiol. 2008, 18: 548-569. 10.1007/s00330-007-0777-9. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS: Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011, 306: 2110-2119. 10.1001/jama.2011.1670. Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B: Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006, 113: 1287-1294. 10.1161/CIRCULATIONAHA.105.575118. Dill T, Schachinger V, Rolf A, Mollmann S, Thiele H, Tillmanns H, Assmus B, Dimmeler S, Zeiher AM, Hamm C: Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy. Am Heart J. 2009, 157: 541-547. 10.1016/j.ahj.2008.11.011. Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR: Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J. 2011, 32: 1736-1747. 10.1093/eurheartj/ehq449. Wohrle J, Merkle N, Mailander V, Nusser T, Schauwecker P, von Scheidt F, Schwarz K, Bommer M, Wiesneth M, Schrezenmeier H, Hombach V: Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol. 2010, 105: 804-812. 10.1016/j.amjcard.2009.10.060. Grieve SM, Bhindi R, Seow J, Doyle A, Turner AJ, Tomka J, Lay W, Gill A, Hunyor SN, Figtree GA: Microvascular obstruction by intracoronary delivery of mesenchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circ Heart Fail. 2011, 3: e5-6. Wong DT, Leung MC, Das R: Intracoronary ECG ST-segment recovery during primary percutaneous intervention for ST-segment myocardial infarction: Insights from a cardiac MRI study. Catheter Cardiovasc Interv. 2012, Epub ahead of print Weaver JC, Ramsay DD, Rees D, Binnekamp MF, Prasan AM, McCrohon JA: Dynamic changes in ST segment resolution after myocardial infarction and the association with microvascular injury on cardiac magnetic resonance imaging. Heart Lung Circ. 2011, 20: 111-118. 10.1016/j.hlc.2010.09.006. Appelbaum E, Kirtane AJ, Clark A, Pride YB, Gelfand EV, Harrigan CJ, Kissinger KV, Manning WJ, Gibson CM: Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction. J Thromb Thrombolysis. 2009, 27: 123-129. 10.1007/s11239-008-0197-y. Kim JS, Ko YG, Yoon SJ, Moon JY, Kim YJ, Choi BW, Choi D, Jang Y: Correlation of serial cardiac magnetic resonance imaging parameters with early resolution of ST-segment elevation after primary percutaneous coronary intervention. Circ J. 2008, 72: 1621-1626. 10.1253/circj.CJ-08-0232. Marra MP, Corbetti F, Cacciavillani L, Tarantini G, Ramondo AB, Napodano M, Basso C, Lacognata C, Marzari A, Maddalena F, Iliceto S: Relationship between myocardial blush grades, staining, and severe microvascular damage after primary percutaneous coronary intervention a study performed with contrast-enhanced magnetic resonance in a large consecutive series of patients. Am Heart J. 2010, 159: 1124-1132. 10.1016/j.ahj.2010.03.007. Vicente J, Mewton N, Croisille P, Staat P, Bonnefoy-Cudraz E, Ovize M, Revel D: Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions. Catheter Cardiovasc Interv. 2009, 74: 1000-1007. 10.1002/ccd.22157. Porto I, Burzotta F, Brancati M, Trani C, Lombardo A, Romagnoli E, Niccoli G, Natale L, Bonomo L, Crea F: Relation of myocardial blush grade to microvascular perfusion and myocardial infarct size after primary or rescue percutaneous coronary intervention. Am J Cardiol. 2007, 99: 1671-1673. 10.1016/j.amjcard.2007.01.045. Gerber BL, Belge B, Legros GJ, Lim P, Poncelet A, Pasquet A, Gisellu G, Coche E, Vanoverschelde J-LJ: Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006, 113: 823-833. 10.1161/CIRCULATIONAHA.104.529511. Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U, Gold HK, Jang IK, Brady TJ, Cury RC: Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. Radiology. 2008, 247: 49-56. 10.1148/radiol.2471070332. Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP, Schuleri KH, Fernandes VR, Zviman M, Nazarian S: Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006, 113: 394-404. 10.1161/CIRCULATIONAHA.105.521450.